Tokushima, Japan

Tomoyuki Kawaguchi


Average Co-Inventor Count = 9.1

ph-index = 1

Forward Citations = 42(Granted Patents)


Company Filing History:


Years Active: 1991-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomoyuki Kawaguchi: Innovator in Pharmaceutical Development

Introduction

Tomoyuki Kawaguchi is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of 2 patents to his name, Kawaguchi's work is recognized for its potential impact on various medical conditions.

Latest Patents

Kawaguchi's latest patents include innovative compounds that address critical health issues. One of his notable inventions is a series of indole derivatives, which possess an inhibitory effect against superoxide radicals released from macrophage cells. These compounds are particularly useful in treating autoimmune diseases, arteriosclerosis, and renal insufficiency. Another significant patent is a novel pyrazinoxide compound, NF-1616-904, which is derived from a microorganism and shows promise in preventing and treating diseases caused by superoxide radicals and nephritis.

Career Highlights

Kawaguchi is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving patient outcomes through innovative pharmaceutical solutions.

Collaborations

Kawaguchi collaborates with esteemed colleagues, including Yoshimasa Nakano and Hitoshi Tone, to further enhance the scope and impact of his research.

Conclusion

Tomoyuki Kawaguchi's contributions to pharmaceutical innovation highlight his dedication to addressing complex health challenges. His patents reflect a commitment to developing effective treatments that can significantly improve the quality of life for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…